Supplier profile
Bristol-Myers Squibb; S.A.
Every public-sector award we hold for this supplier, across Spain, France, Luxembourg and Portugal, from 28 May 2008 to 30 Sept 2026.
Awards won
306
all time
Attributed value
€398.5m
68 shared, unvalued
Buyers
170
public bodies
Active
2008–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Centro Hospitalar Lisboa Norte; EPE | 13 | €1.8m |
| Centro Hospitalar Lisboa Norte, EPE | 12 | €2.0m |
| Osakidetza | 10 | €27.1m |
| Corporació Sanitària Parc Taulí | 7 | €2.3m |
| OSAKIDETZA - Servicio Vasco de Salud - Organización Central | 7 | €93.8m |
| Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil | 5 | €3.5m |
| Servicio Madrileño de Salud, Hospital Universitario 12 de Octubre | 5 | €1.9m |
| Centro Hospitalar Lisboa Norte, E. P. E. | 4 | €1.5m |
| Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín | 4 | €459k |
| Ente Público Hospital Universitario de Fuenlabrada | 4 | €1.5m |
What they win
Awards
Showing 1–25 of 306 awards we hold
- Spain – Pharmaceutical products – ALMERIA 2º CBAM CONTR 2026 0000202933_2 ↗Servicio Andaluz de Salud. Central Provincial de Compras de Almería€352kawarded 30 Sept 2026
- Spain – Pharmaceutical products – ALMERIA 2º CBAM CONTR 2026 0000331090 ↗Servicio Andaluz de Salud. Central Provincial de Compras de Almería€350kawarded 26 Sept 2026
- Spain – Pharmaceutical products – Acuerdo Marco para el suministro de medicamentos sin competencia para los hospitales del Servicio Cántabro de Salud (Principios activos Luspatercept, Mavacamten, Fedratinib, Belatacept, Abatacept, Deucravacitinib, Ipilimumab, Ozanimod). ↗Servicio Cántabro de Saludawarded 22 Aug 2026
- Acuerdo Marco para el suministro de medicamentos sin competencia para los hospitales del Servicio Cántabro de Salud (Principios activos Luspatercept, Mavacamten, Fedratinib, Belatacept, Abatacept, Deucravacitinib, Ipilimumab, Ozanimod). ↗Servicio Cántabro de Salud€9.2mawarded 21 Aug 2026
- Suministro de medicamentos de Uso Humano Tipo II (Exclusivos), incluidos en los acuerdos marco con número de expediente (23/S/24/SU/DG/N/[AM21-AM28]) ↗Gerencia de Servicios Sanitarios de La Gomera€10kawarded 9 Jul 2026
- Spain – Pharmaceutical products – Suministro de Lisocabtagen maraleucel (DOE) ↗OSAKIDETZA - Servicio Vasco de Salud - Organización Central€64.7mawarded 24 Jun 2026
- Spain – Pharmaceutical products – CBAM 578/2025 BRISTOL/01 ↗SERVICIO ANDALUZ DE SALUD. HOSPITAL UNIVERSITARIO REGIONAL DE MÁLAGA€3.7mawarded 24 Jun 2026
- Spain – Pharmaceutical products – HUELVA 1º CBAM AM 2204/2025 (Nº SIGLO 578/2025 ;CCA:+6.I+E9Q8J) ↗Servicio Andaluz de Salud. Hospital Universitario Juan Ramón Jiménez€420kawarded 16 Jun 2026
- Spain – Pharmaceutical products – JAEN CBAM BRISTOL-MYERS SQUIBB, S.A. AM 376/2025 ↗Servicio Andaluz de Salud. Hospital Universitario de Jaén€500kawarded 5 Jun 2026
- Spain – Pharmaceutical products – CONTR 2026 200899 CBAM-1 GRANADA AMC 2204-2025 (578/2025) MEDICAMENTOS EXCLUSIVOS ↗Servicio Andaluz de Salud. Hospital Universitario Virgen de las Nievesawarded 29 May 2026
- Spain – Pharmaceutical products – JAÉN CBAM AM 1229/2024 BRISTOL-MYERS SQUIBB S.A. ↗Servicio Andaluz de Salud. Hospital Universitario de Jaén.€435kawarded 24 Apr 2026
- Spain – Pharmaceutical products – A.M suministros CONTR 2025 0000519166 ↗Servicio Andaluz de Salud. Servicios Centralesshared awardawarded 16 Apr 2026
- Spain – Pharmaceutical products – Suministro de medicamentos para el Hospital Universitari Vall d'Hebrón ↗ICS - Hospital Universitari Vall Hebron€611kawarded 12 Mar 2026
- Spain – Pharmaceutical products – Suministro de Belatacept (DOE) ↗OSAKIDETZA - Servicio Vasco de Salud - Organización Central€727kawarded 3 Feb 2026
- Contrato basado en el acuerdo marco de medicamentos de uso humano II ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€157kawarded 9 Dec 2025
- Spain – Various medicinal products – Suministro de medicamentos de uso humano tipo II (medicamentos exclusivos) ↗Gerencia de Servicios Sanitarios del Área de Salud de Lanzaroteawarded 27 Nov 2025
- Suministro de medicamentos de uso humano Tipo II (Exclusivos), para el Complejo Hospitalario Universitario Insular Materno Infantil de Gran Canaria. ↗Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil€962kawarded 25 Nov 2025
- Suministro de medicamentos de uso humano Tipo II (Exclusivos), para el Complejo Hospitalario Universitario Insular Materno Infantil de Gran Canaria. ↗Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil€1.8mawarded 25 Nov 2025
- Suministro de medicamentos de uso humano Tipo II (Exclusivos), para el Complejo Hospitalario Universitario Insular Materno Infantil de Gran Canaria. ↗Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil€25kawarded 25 Nov 2025
- Suministro de medicamentos de uso humano Tipo II (Exclusivos), para el Complejo Hospitalario Universitario Insular Materno Infantil de Gran Canaria. ↗Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil€183kawarded 25 Nov 2025
- Suministro de medicamentos de uso humano Tipo II (Exclusivos), para el Complejo Hospitalario Universitario Insular Materno Infantil de Gran Canaria. ↗Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil€565kawarded 25 Nov 2025
- Spain – Pharmaceutical products – CBAM del AM CONTR 2024 / 1031923 (PNAMSP 133/2024 ) BRISTOL MYERS SQUIBB ↗Servicio Andaluz de Salud. Área Hospitalaria Virgen del Rocío.€6.3mawarded 21 Nov 2025
- Contrato basado en acuerdo marco para el suministro de medicamentos de uso humano II ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€184kawarded 28 Oct 2025
- Contrato basado en acuerdo marco para el suministro de medicamentos de uso humano II ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€53kawarded 28 Oct 2025
- Spain – Pharmaceutical products – CONTR 2025 0000413325 ↗Servicio Andaluz de Salud. Hospital Universitario de Málagashared awardawarded 25 Oct 2025
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
- Bristol Myers Squibb413 awards · £3.3m
- BRISTOL-MYERS SQUIBB S.R.L.124 awards
- Bristol-Myers Squibb AB11 awards
- Bristol Myers Squibb, S. L.4 awards
- BRISTOL-MYERS SQUIBB, S.L.U.2 awards
- Bristol MYERS Squibb SpA2 awards
- Bristol-Myers Squibb (Finland) AB1 award
- Bristol Myers Squibb NV1 award
- Bristol-Myers Squibb Oy Ab1 award
- bristol myers squibb sarl1 award
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.